Lymphoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have signed a consent form agreeing to take part in the study
- People who have been diagnosed with cutaneous T-cell lymphoma (a type of skin lymphoma) and have not responded well to skin-directed treatments such as steroid creams, nitrogen mustard, or light therapy — this applies to both early-stage (stage I–IIA) and more advanced-stage (stage IIB–IV) disease
- People between 18 and 75 years of age
- People with an expected survival of more than 3 months
Who may not be able to join:
- People who have received any cancer treatment other than skin-directed therapies (such as light therapy, steroid creams, or nitrogen mustard) in the month before enrolling
- People who have two or more different types of primary skin T-cell lymphoma at the same time
- People who currently have another type of cancer and are still receiving treatment for it
- People who have certain other active health conditions that could increase the risks of the study treatment or interfere with taking part, including epilepsy, autoimmune diseases, serious liver failure, or reduced kidney function (specifically, a kidney filtration rate below 50 ml/min)
- People who have uncontrolled medical conditions, including active infections, significant wounds that are not healing, heart conditions such as heart failure or unstable chest pain or irregular heart rhythms, significant lung disease that causes breathlessness at rest or with minimal activity, or mental health or other conditions that may make it difficult to follow the study requirements
- People who are pregnant, planning to become pregnant within 2 years, or currently breastfeeding
- People who are already taking part in another clinical trial involving an investigational treatment (observational studies or questionnaire-based studies may be acceptable — confirm with trial site)
- People whose situation does not fit the requirements of the study protocol (confirm with trial site)
- People who, in the opinion of the study doctor, are not suitable for the study for any other reason
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: YANG WANG, MD, Peking University First Hospital
Phone: 86-10-83572350
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
time to next treatment (TTNT)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.